Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Unspecified Adult Solid Tumor, Protocol Specific 5 Carcinoma, Intraductal, Noninfiltrating 3 Prostatic Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Hepatitis C 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hot Flashes 1 Gliosarcoma 1 Glioblastoma 1 Fanconi Anemia 1

Interventions

Cyclophosphamide 53 Etoposide 33 Temozolomide 28 Irinotecan 28 Melphalan 25 Filgrastim 25 Topotecan 24 Carboplatin 24 3-Iodobenzylguanidine 23 Isotretinoin 20 Granulocyte Colony-Stimulating Factor 17 sargramostim 16 humanized 3F8 anti-GD2 monoclonal antibody 16 dinutuximab 16 Granulocyte-Macrophage Colony-Stimulating Factor 16 fludarabine 15 Vincristine 15 Doxorubicin 15 Cisplatin 15 Peripheral Blood Stem Cell Transplantation 14 Interleukin-2 14 Busulfan 13 naxitamab 12 Thiotepa 12 Radiotherapy 12 aldesleukin 11 fludarabine phosphate 10 etoposide phosphate 8 Mesna 8 Ifosfamide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroblastoma × Chromatography, High Pressure Liquid × Clear all

NCT00646230 2026-04-14

IV Fenretinide

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡